| Old Articles: <Older 52391-52400 Newer> |
|---|
 |
The Motley Fool
October 5, 2011
Shubh Datta |
At Walgreen, It's Payback Time Walgreen buys back shares and raises its dividend.   |
The Motley Fool
October 5, 2011
Brian Orelli |
1 Sure Sign of an FDA Approval Transcept Pharmaceuticals shoots up 34% after announcing that the FDA had classified its resubmission as a class 1 response. |
The Motley Fool
October 5, 2011
Travis Hoium |
Alpha Natural Resources Shares Jumped: What You Need to Know Shares of coal producer Alpha Natural Resources jumped as much as 13% in trading today as coal stocks emerged from a long slump. |
The Motley Fool
October 5, 2011
Eben Esterhuizen |
Investing 101: 3 Tech Giants With Bloated Inventories Looking for a list of mega-cap tech stocks that could be in trouble? Look at these three: LM Ericsson... Research In Motion... Agilent Technologies... |
The Motley Fool
October 5, 2011
Evan Niu |
Yum! Brands Serves Up Profits KFC parent Yum! Brands reported quarterly earnings for its fiscal third quarter of 2011 with its restaurants in China stealing the show. |
The Motley Fool
October 5, 2011
Eben Esterhuizen |
Investing 101: Stocks Under $2 Boosted by Insider and Hedge Fund Buying Interested in analyzing the trades of company insiders and sophisticated big money managers? Start with these six: Midway Gold... Capital Bank... Valence... Seacoast Banking... Identive Group... The McClatchy Company... |
The Motley Fool
October 5, 2011
Lipman & Esterhuizen |
Institutional Trends: Big Money Is Rushing to Dump Oil Stocks How long before most of the bad news is priced into these oil stocks?: RPC... Crosstex Energy... Hornbeck Offshore Services... |
The Motley Fool
October 5, 2011
Anders Bylund |
OmniVision Technologies Shares Jumped: What You Need to Know Shares of camera-chip designer OmniVision Technologies are having the good kind of Kodak moment, following Tuesday's 20% jump with a 12.6% surge in intraday trading today. |
The Motley Fool
October 5, 2011
Brian Stoffel |
Stocks Are a Good Investment Now; Here's Why If you've been sitting on the sidelines while the stock market slides, here are some companies to consider getting your feet wet in. |
The Motley Fool
October 5, 2011
Arlene Weintraub |
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom Merck readies itself to enter this potential new market. |
| <Older 52391-52400 Newer> Return to current articles. |
